Contract testing laboratories now have access to GMP-grade StemFit® for Differentiation from AMSBIO—a powerful, animal-free medium designed for the reproducible differentiation of human pluripotent stem cells. With full GMP compliance, this medium is ideal for labs supporting clinical trial manufacturing, regulatory testing, and therapeutic development.
The chemically defined formulation eliminates variability and contamination risks, while maintaining cost-efficiency—essential for labs managing large-scale, multi-client workflows.
Benefits for Contract Laboratories
- Clinical-grade readiness supports trials and therapy development.
- Defined and reproducible composition ensures protocol integrity.
- Animal-origin free for reduced immunogenic concerns.
- Streamlined material sourcing with full GMP product line by 2025.
- Budget-aligned pricing aids adoption across diverse client projects.
With growing trust in StemFit® across academia and biotech—highlighted by nearly 1,500 citations—contract labs can confidently integrate this solution into regulated environments with minimal disruption.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. The original press release was provided by AMSBIO.
